Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Johnson and Johnson
Harvard Business School
McKinsey
Mallinckrodt

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020066

See Plans and Pricing

« Back to Dashboard

NDA 020066 describes NICORETTE (MINT), which is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from three suppliers. Additional details are available on the NICORETTE (MINT) profile page.

The generic ingredient in NICORETTE (MINT) is nicotine polacrilex. There are thirty drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
Summary for 020066
Tradename:NICORETTE (MINT)
Applicant:Glaxosmithkline
Ingredient:nicotine polacrilex
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020066
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 020066 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0158 0135-0158-07 1 BLISTER PACK in 1 CARTON (0135-0158-07) > 110 GUM, CHEWING in 1 BLISTER PACK
NICORETTE nicotine polacrilex GUM, CHEWING;BUCCAL 020066 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0158 0135-0158-10 1 BLISTER PACK in 1 CARTON (0135-0158-10) > 170 GUM, CHEWING in 1 BLISTER PACK

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 4MG BASE
Approval Date:Feb 9, 1996TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Apr 30, 2028Product Flag?YSubstance Flag?Delist Request?

Profile for product number 003

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 4MG BASE
Approval Date:Dec 23, 1998TE:RLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:OTCDosage:GUM, CHEWING;BUCCALStrengthEQ 4MG BASE
Approval Date:Sep 25, 2000TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Mallinckrodt
Dow
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.